Twelve years ago, a Boston Globe story raised doubts some Canadian researcher had about bone scans for the diagnosis of osteoporosis. It was a scary story to write. Doctors, some patient advocacy groups, researchers and drug makers were enthusiastic about the new-found ability to measure bone density and the development of bisphosphonates like Fosamax to treat it. Osteoporosis was under-treated, they said. … Continue reading FDA says – Ask yourself, your doc: Should I take drugs for #osteopenia, #osteoporosis or bone loss?
These days, space is dear in newspapers. So, while the today’s Globe story offeres some much needed clarification about the state of osteoporosis treatment, here are a few additional points. The Frax test is an alternative or adjunct to bone density tests. Some say density is only one measure of fragility and fracture risk. (Disclosure: Please note the … Continue reading Beyond the Globe’s story on osteoporosis